These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10917612)

  • 1. Recent advances in the biochemistry of glycosphingolipid metabolism.
    Kolter T; Doering T; Wilkening G; Werth N; Sandhoff K
    Biochem Soc Trans; 1999 Aug; 27(4):409-15. PubMed ID: 10917612
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
    Jeyakumar M; Butters TD; Dwek RA; Platt FM
    Neuropathol Appl Neurobiol; 2002 Oct; 28(5):343-57. PubMed ID: 12366816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry of glycosphingolipid degradation.
    Sandhoff K; Kolter T
    Clin Chim Acta; 1997 Oct; 266(1):51-61. PubMed ID: 9435988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipid hydrolases and activator proteins.
    Bierfreund U; Kolter T; Sandhoff K
    Methods Enzymol; 2000; 311():255-76. PubMed ID: 10563332
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease.
    Karageorgos L; Hein L; Rozaklis T; Adams M; Duplock S; Snel M; Hemsley K; Kuchel T; Smith N; Hopwood JJ
    Neurobiol Dis; 2016 Jul; 91():143-54. PubMed ID: 26976737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperacidification of trans-Golgi network and endo/lysosomes in melanocytes by glucosylceramide-dependent V-ATPase activity.
    van der Poel S; Wolthoorn J; van den Heuvel D; Egmond M; Groux-Degroote S; Neumann S; Gerritsen H; van Meer G; Sprong H
    Traffic; 2011 Nov; 12(11):1634-47. PubMed ID: 21810155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Function and relevance of activator proteins for glycolipid degradation].
    Sandhoff K
    Seikagaku; 1985 Feb; 57(2):87-102. PubMed ID: 3925052
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain.
    Hallett PJ; Huebecker M; Brekk OR; Moloney EB; Rocha EM; Priestman DA; Platt FM; Isacson O
    Neurobiol Aging; 2018 Jul; 67():189-200. PubMed ID: 29735433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
    Baek RC; Kasperzyk JL; Platt FM; Seyfried TN
    Neurochem Int; 2008 May; 52(6):1125-33. PubMed ID: 18207611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective enrichment of phytosphingosine in glycosphingolipids of isolated human thyrocytes as compared to the whole thyroid.
    Bouchon B; Portoukalian J; Orgiazzi J; Bornet H
    Biochem Biophys Res Commun; 1987 Mar; 143(3):827-31. PubMed ID: 3566758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen retards glycosphingolipid metabolism in human cancer cells.
    Cabot MC; Giuliano AE; Volner A; Han TY
    FEBS Lett; 1996 Sep; 394(2):129-31. PubMed ID: 8843149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin.
    Platt FM; Neises GR; Reinkensmeier G; Townsend MJ; Perry VH; Proia RL; Winchester B; Dwek RA; Butters TD
    Science; 1997 Apr; 276(5311):428-31. PubMed ID: 9103204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into glycosphingolipid functions--storage, lipid rafts, and translocators.
    Sillence DJ
    Int Rev Cytol; 2007; 262():151-89. PubMed ID: 17631188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential.
    Hanisch FG; Sölter J; Jansen V; Lochner A; Peter-Katalinic J; Uhlenbruck G
    Br J Cancer; 1990 Jun; 61(6):813-20. PubMed ID: 2372482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of sphingolipid and glycosphingolipid metabolism during neuronal growth and development.
    Futerman AH; Boldin SA; Brann AB; Pelled D; Meivar-Levy I; Zisling R
    Biochem Soc Trans; 1999 Aug; 27(4):432-7. PubMed ID: 10917616
    [No Abstract]   [Full Text] [Related]  

  • 16. [Novel catabolic pathway of glycosphingolipids that includes a cytosolic glucocerebrosidase, klotho-related protein (KLrP)].
    Hayashi Y; Okino N; Kakuta Y; Ito M
    Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1462-7. PubMed ID: 21089349
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of complex carbohydrate storage in four lysosomal storage diseases: fucosidosis, GM1-gangliosidosis, GM2-gangliosidosis (Sandhoff variant) and mannosidosis.
    Dawson G; Chen Tsay G
    Biochem Exp Biol; 1977; 13(1):15-25. PubMed ID: 418790
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal connection of mutant PS1 to glycosphingolipids metabolism].
    Mutoh T; Yano S; Yamamoto H
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2473-8. PubMed ID: 15553004
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological Modulation of Glycosphingolipid Metabolism.
    Inokuchi JI; Ode T; Hara-Yokoyama M
    Methods Mol Biol; 2018; 1804():401-410. PubMed ID: 29926420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycosphingolipidoses-from disease to basic principles of metabolism.
    Schuette CG; Doering T; Kolter T; Sandhoff K
    Biol Chem; 1999; 380(7-8):759-66. PubMed ID: 10494825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.